Protecting Your Science in the Spotlight: Lessons from the 10x Genomics
The recent announcement that 10x Genomics is acquiring Scale Biosciences for $30 million is a significant milestone in the world of single-cell and spatial biology. This move, which brings advanced technologies like combinatorial indexing and quantum barcoding into the 10x portfolio, is a clear example of a research-first organization expanding its influence and solidifying its market leadership.
However, as a company scales rapidly through acquisitions and partnerships, new challenges emerge, chief among them is the need to protect the intellectual property (IP) that drives innovation. As two teams merge, so do their research projects, collaborators, and potential vulnerabilities. This is precisely where a solution like IPTalons’ Innovation Defender becomes essential.
Innovation Defender is a flagship product built for fast-moving biotech and life sciences teams who need to bulletproof their science. Here's how a company in a similar position to 10x Genomics could leverage its features to secure its new, combined enterprise:
Due Diligence with Grant Hopper AI: The acquisition of Scale Biosciences means 10x Genomics is also acquiring its network. With Innovation Defender's Grant Hopper AI, they can quickly vet Scale's suppliers, sub-awardees, investors, and collaborators. This tool helps identify and mitigate risks from competitors who might gain access to innovation through trusted partners, a critical step in a successful merger.
Training with Innovation Defense Academy: Protecting innovation starts with your people. Merging two teams requires a unified approach to security. The Innovation Defense Academy provides a comprehensive online platform to train all employees on the latest best practices in IP protection and research security, creating a strong, cohesive first line of defense against the theft of innovation.
Expert Guidance and Consultation: Building a robust research security program can be resource-intensive, but it doesn't have to be. As a subscriber to Innovation Defender, a company can access seasoned subject matter experts who provide guidance on navigating the evolving landscape of competition and insider risk. This expert consultation is invaluable for integrating the two companies' security protocols and ensuring a smooth, secure transition.
The 10x Genomics acquisition of Scale Biosciences is an exciting development, but it also serves as a powerful reminder: as your organization gains momentum, the need to protect, position, and fund your innovations smarter becomes more critical than ever. With Innovation Defender, science-forward teams can scale with confidence, knowing their intellectual property is secure every step of the way.
